These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Cyclic guanosine monophosphate production in the pituitary: stimulation by C-type natriuretic peptide and inhibition by gonadotropin-releasing hormone in alpha T3-1 cells. McArdle CA; Poch A; Käppler K Endocrinology; 1993 May; 132(5):2065-72. PubMed ID: 7682940 [TBL] [Abstract][Full Text] [Related]
30. Effects of tilting and volume loading on plasma levels and urinary excretion of relaxin, NT-pro-ANP, and NT-pro-BNP in male volunteers. Heringlake M; Heide C; Bahlmann L; Eichler W; Pagel H; Schmucker P; Wergeland R; Armbruster FP; Klaus S J Appl Physiol (1985); 2004 Jul; 97(1):173-9. PubMed ID: 14990550 [TBL] [Abstract][Full Text] [Related]
31. C-type natriuretic peptide inhibits thrombin- and angiotensin II-stimulated endothelin release via cyclic guanosine 3',5'-monophosphate. Kohno M; Horio T; Yokokawa K; Kurihara N; Takeda T Hypertension; 1992 Apr; 19(4):320-5. PubMed ID: 1313393 [TBL] [Abstract][Full Text] [Related]
32. Natriuretic peptides as regulatory mediators of secretory activity in the digestive system. Sabbatini ME Regul Pept; 2009 Apr; 154(1-3):5-15. PubMed ID: 19233231 [TBL] [Abstract][Full Text] [Related]
34. Neutral endopeptidase regulates C-type natriuretic peptide metabolism but does not potentiate its bioactivity in vivo. Brandt RR; Mattingly MT; Clavell AL; Barclay PL; Burnett JC Hypertension; 1997 Aug; 30(2 Pt 1):184-90. PubMed ID: 9260978 [TBL] [Abstract][Full Text] [Related]
35. Plasma levels of atrial natriuretic peptide and brain natriuretic peptide following intravenous saline infusion in oedematous chronic obstructive pulmonary disease and non-oedematous chronic obstructive pulmonary disease. Sheedy W; Stewart AG; Morice AH Respiration; 1996; 63(6):376-80. PubMed ID: 8933657 [TBL] [Abstract][Full Text] [Related]
36. Atrial natriuretic peptide and water and electrolyte transport in the human jejunum. Brunner J; Lübcke R; Barbezat GO; Yandle TG; Espiner EA Gut; 1991 Jun; 32(6):635-9. PubMed ID: 1648026 [TBL] [Abstract][Full Text] [Related]
37. Cyclic guanosine monophosphate responses to atrial natriuretic factor, brain natriuretic peptide, but not C-type natriuretic peptide, and the characterization of their receptors in rat medullary thick ascending limb. Luk JK; Wong EF; Sun A; Wong NL Metabolism; 1994 Dec; 43(12):1531-5. PubMed ID: 7990707 [TBL] [Abstract][Full Text] [Related]
38. Effect of vasoactive intestinal polypeptide (VIP) on the net movement of electrolytes and water and glucose absorption in the jejunal loop of sheep. Hyun HS; Onaga T; Mineo H; Kato S J Vet Med Sci; 1995 Oct; 57(5):865-9. PubMed ID: 8593294 [TBL] [Abstract][Full Text] [Related]
39. Renal and vascular effects of C-type and atrial natriuretic peptides in humans. Pham I; Sediame S; Maistre G; Roudot-Thoraval F; Chabrier PE; Carayon A; Adnot S Am J Physiol; 1997 Oct; 273(4):R1457-64. PubMed ID: 9362312 [TBL] [Abstract][Full Text] [Related]